Free Trial

Veru (VERU) Competitors

Veru logo
$0.49 0.00 (-0.02%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$0.50 +0.01 (+1.06%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VERU vs. NATR, MED, EL, PBH, IPAR, HLF, USNA, NUS, ABEO, and TRDA

Should you be buying Veru stock or one of its competitors? The main competitors of Veru include Nature's Sunshine Products (NATR), Medifast (MED), Estée Lauder Companies (EL), Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Abeona Therapeutics (ABEO), and Entrada Therapeutics (TRDA).

Veru vs.

Veru (NASDAQ:VERU) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, community ranking, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

Nature's Sunshine Products has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veru$16.89M4.25-$37.80M-$0.24-2.04
Nature's Sunshine Products$456.62M0.58$15.08M$0.5327.21

Veru received 105 more outperform votes than Nature's Sunshine Products when rated by MarketBeat users. Likewise, 69.82% of users gave Veru an outperform vote while only 63.88% of users gave Nature's Sunshine Products an outperform vote.

CompanyUnderperformOutperform
VeruOutperform Votes
273
69.82%
Underperform Votes
118
30.18%
Nature's Sunshine ProductsOutperform Votes
168
63.88%
Underperform Votes
95
36.12%

In the previous week, Veru had 5 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 7 mentions for Veru and 2 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 0.91 beat Veru's score of -0.01 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Veru
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Nature's Sunshine Products
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Veru has a beta of -0.74, indicating that its share price is 174% less volatile than the S&P 500. Comparatively, Nature's Sunshine Products has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500.

47.2% of Veru shares are held by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are held by institutional investors. 14.9% of Veru shares are held by insiders. Comparatively, 4.7% of Nature's Sunshine Products shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Nature's Sunshine Products has a net margin of 3.81% compared to Veru's net margin of -223.85%. Nature's Sunshine Products' return on equity of 11.08% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
Veru-223.85% -112.75% -67.54%
Nature's Sunshine Products 3.81%11.08%7.23%

Veru currently has a consensus price target of $4.00, suggesting a potential upside of 716.66%. Nature's Sunshine Products has a consensus price target of $18.33, suggesting a potential upside of 27.14%. Given Veru's higher possible upside, analysts clearly believe Veru is more favorable than Nature's Sunshine Products.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veru
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Nature's Sunshine Products
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Nature's Sunshine Products beats Veru on 11 of the 17 factors compared between the two stocks.

Get Veru News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERU vs. The Competition

MetricVeruPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$71.80M$6.47B$5.33B$8.39B
Dividend YieldN/A2.64%5.21%4.11%
P/E Ratio-1.889.0626.7319.70
Price / Sales4.25251.66389.54120.67
Price / CashN/A65.8538.2534.62
Price / Book2.726.456.764.50
Net Income-$37.80M$143.98M$3.23B$248.22M
7 Day Performance-5.72%0.38%0.43%-0.78%
1 Month Performance-10.80%2.14%9.07%11.53%
1 Year Performance-61.43%-0.33%18.56%8.99%

Veru Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERU
Veru
1.5057 of 5 stars
$0.49
0.0%
$4.00
+716.7%
-64.2%$71.80M$16.89M-1.88230
NATR
Nature's Sunshine Products
2.7467 of 5 stars
$14.88
+0.1%
$18.33
+23.2%
-7.6%$273.06M$456.62M16.91850
MED
Medifast
3.3694 of 5 stars
$13.98
-0.1%
$16.50
+18.0%
-45.2%$153.65M$543.45M77.67870Positive News
Analyst Revision
EL
Estée Lauder Companies
4.2673 of 5 stars
$65.35
+0.3%
$75.20
+15.1%
-50.7%$23.51B$14.79B-33.5163,000Positive News
Analyst Revision
PBH
Prestige Consumer Healthcare
3.6948 of 5 stars
$89.01
-0.1%
$93.33
+4.9%
+31.1%$4.40B$1.14B20.85540Positive News
IPAR
Inter Parfums
3.9549 of 5 stars
$128.17
+1.1%
$157.60
+23.0%
+11.0%$4.12B$1.47B27.50530Trending News
Analyst Revision
HLF
Herbalife
4.5012 of 5 stars
$6.93
-1.8%
$11.50
+65.9%
-38.3%$705.80M$4.95B2.7810,100Analyst Downgrade
USNA
USANA Health Sciences
4.2847 of 5 stars
$30.07
-0.7%
$36.00
+19.7%
-38.1%$559.99M$876.24M10.631,900Analyst Upgrade
NUS
Nu Skin Enterprises
3.087 of 5 stars
$7.47
-1.5%
$6.88
-8.0%
-46.2%$371.43M$1.68B-2.5313,400Positive News
ABEO
Abeona Therapeutics
3.7866 of 5 stars
$6.23
+2.1%
$18.50
+197.0%
+53.4%$304.02M$3.50M-2.32N/ATrending News
Analyst Revision
TRDA
Entrada Therapeutics
3.1089 of 5 stars
$8.01
-1.0%
$25.67
+220.4%
-52.4%$304.00M$172.22M5.04110News Coverage
Analyst Forecast
Analyst Revision
Gap Up

Related Companies and Tools


This page (NASDAQ:VERU) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners